Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Jun 2019 07:00 AM
RNS
Positive SRA737 data presented at ASCO
16 May 2019 07:00 AM
RNS
ASCO abstracts for SRA737 published
08 May 2019 12:41 PM
RNS
Sareum notes Sierra Oncology Q1 2019 Results
30 Apr 2019 07:00 AM
RNS
Sareum to Present at BioTrinity 2019 in London
23 Apr 2019 07:00 AM
RNS
SRA737 Phase I/IIa data to be presented at ASCO
02 Apr 2019 07:00 AM
RNS
Preclinical Data for SRA737 Presented at AACR 2019
12 Mar 2019 07:00 AM
RNS
Sareum Holdings PLC Issue of Options
04 Mar 2019 07:00 AM
RNS
HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018
28 Feb 2019 02:04 PM
RNS
Sierra Oncology has reported its 2018 Results
28 Feb 2019 08:14 AM
RNS
New SRA737 preclin data to be presented at AACR
23 Jan 2019 01:38 PM
RNS
Sierra Oncology to present SRA737 at DDR Tx Summit
18 Dec 2018 12:35 PM
RNS
Results of AGM
18 Dec 2018 07:00 AM
RNS
AGM Statement
30 Nov 2018 11:17 AM
RNS
Amendment to Preclinical Efficacy Announcement
30 Nov 2018 07:45 AM
RNS
Preclinical Efficacy for Immunotherapy Combination
15 Nov 2018 10:24 AM
RNS
Preclinical Data for SRA737 in Ovarian Cancer
14 Nov 2018 07:00 AM
RNS
AGM NOTICE
13 Nov 2018 07:00 AM
RNS
Directorate Change
08 Nov 2018 12:28 PM
RNS
Sierra Oncology Q3 2018 Results
26 Oct 2018 07:00 AM
RNS
Completion of Placing
01 Oct 2018 07:00 AM
RNS
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
27 Sep 2018 01:03 PM
RNS
Notice of Results
26 Sep 2018 07:00 AM
RNS
TYK2/JAK1 selected for certain cancers
11 Sep 2018 07:00 AM
RNS
Pre-Close Trading Statement
10 Sep 2018 07:00 AM
RNS
Selection of TYK2/JAK1 for autoimmune diseases
09 Aug 2018 01:15 PM
RNS
Sareum notes Sierra Oncology Q2 2018 Results
11 Jul 2018 09:38 AM
RNS
Notification of PCA Shareholding
15 Jun 2018 07:00 AM
RNS
Advisers
31 May 2018 07:00 AM
RNS
Sareum regains rights to Aurora+FLT3 inhibitors
10 May 2018 12:21 PM
RNS
SRA737 trial update in Sierra Oncology Q1 Results
24 Apr 2018 07:00 AM
RNS
Sareum to Present at BioTrinity 2018 in London
17 Apr 2018 12:45 PM
RNS
AACR 2018 Update
15 Mar 2018 07:00 AM
RNS
Late-breaker abstract for SRA737 accepted for AACR
13 Mar 2018 07:00 AM
RNS
Interim Results
27 Feb 2018 12:50 PM
RNS
Sierra Oncology expands SRA737 development program
22 Feb 2018 07:00 AM
RNS
Preclinical synergy of sra737 and PARP inhibitor
13 Feb 2018 07:00 AM
RNS
Notice of Interim Results
20 Dec 2017 11:00 AM
RNS
Issue of Options
19 Dec 2017 07:00 AM
RNS
Patent Grants in Japan & China for TYK2 Inhibitors
14 Dec 2017 11:01 AM
RNS
Result of AGM
14 Dec 2017 07:00 AM
RNS
AGM Statement
20 Nov 2017 07:00 AM
RNS
Notice of AGM and Annual Report & Accounts
14 Nov 2017 12:05 PM
RNS
Placing
31 Oct 2017 07:00 AM
RNS
Sierra Reports Preclinical Data for Chk1 Inhibitor
19 Oct 2017 07:00 AM
RNS
Final Results
09 Oct 2017 12:00 PM
RNS
Sierra Oncology host KOL Meeting on 12 Oct in NY
18 Sep 2017 12:00 PM
RNS
Sierra Oncology to host call on Chk1 inhibitor
22 Aug 2017 07:00 AM
RNS
Pre-Close Trading Statement
19 Jun 2017 07:00 AM
RNS
Sareum to Present at the ICCS 2017
05 Jun 2017 12:13 PM
RNS
Chk1 Clinical Trials Update
UK 100

Latest directors dealings